ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP) — Stella

Recruiting

Back to Acute Hepatic Porphyria trials

Trial locations(30 sites)

United States

Clinical Trial Site, Birmingham, Alabama

Clinical Trial Site, Gilbert, Arizona

Clinical Trial Site, San Francisco, California

Clinical Trial Site, Baltimore, Maryland

Clinical Trial Site, Boston, Massachusetts

Key details

Sponsor

Alnylam Pharmaceuticals

Enrollment target

~150 participants

Started

April 2021

Primary completion

April 2027

Age range

12 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov